Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|November 14, 2006
The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapiesKalliopi P Siziopikou, Melody Cobleigh
The Breast Journal|July 20, 2006
The challenging estrogen receptor-negative/ progesterone receptor-negative/HER-2-negative patient: a promising candidate for epidermal growth factor receptor-targeted therapy?Kalliopi P Siziopikou, Reshma Ariga, Kimon E Proussaloglou, et al.
Plos One|April 17, 2018
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?Rachel Mitchell, Lela Buckingham, Melody Cobleigh, et al.
Journal of Managed Care Pharmacy : JMCP|November 27, 2007
New strategies in controlling drug resistanceDavid Frame
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 11, 2007
New strategies in controlling drug resistance in chronic myeloid leukemiaDavid Frame
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 16, 2006
Chronic myeloid leukemia: standard treatment optionsDavid Frame
Journal of the American College of Radiology : JACR|December 14, 2022
Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer SurvivorsJordan Lieberenz, Mia Levy, Rosalinda Alvarado, et al.
Frontiers in Microbiology|June 16, 2023
Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samplesChristina Nowicki, Lucille Ray, Philip Engen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progressionDebu Tripathy, Dennis J Slamon, Melody Cobleigh, et al.
Hereditary Cancer in Clinical Practice|July 27, 2019
Somatic variants of potential clinical significance in the tumors of <i>BRCA</i> phenocopiesLela Buckingham, Rachel Mitchell, Mark Maienschein-Cline, et al.
Pageof 5